Covance Acquires Gene Expression Laboratory from Merck & Co
Covance announces it has entered into a definitive agreement with Merck & Co, Inc. relating to the supply of genomic analysis services.
Read MoreCovance announces it has entered into a definitive agreement with Merck & Co, Inc. relating to the supply of genomic analysis services.
Read MoreA new urine test developed with funding from the Wellcome Trust will allow doctors to diagnose chlamydia infection in men within the hour.
Read MoreOvarian malignancies are a leading cause of cancer death in women because they are usually detected in the late stages when the disease is incurable. Encouraging new research presented by Abbott shows that a novel diagnostic marker, combined with other tests, can be used to more effectively monitor for early-stage ovarian cancer.
Read MoreMichael Cobble, MD, director of Canyons Medical Center in Sandy, Utah, has been appointed as Chief Medical Officer of Atherotech Inc.
Read MoreHHS Secretary Kathleen Sebelius today announced the availability of $200 million to support grants, loans, loan repayment, and scholarships to expand the training of health care professionals. The funds are expected to train approximately 8,000 students and credentialed health professionals by the end of fiscal year 2010.
Read More